Dr Eyre is a consultant haematologist specialising in lymphoid malignancies in Oxford. 

He has completed an MD Doctorate Thesis in 2017.  He is an investigator on several national lymphoid trials and has published over 170 peer-review articles on lymphoma and CLL.  He is the chair of the low-grade lymphoma clinical trial research group and a core member several lymphoma study groups.  He is a member of the BSH guideline writing groups for various lymphoma subtypes and the lead author for the new ESMO Lymphoma guidelines.  ​He is also an Associate Editor at the British Journal of Haematology.